Clinical Trial Update: Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating three fixed dosages of paliperidone extended-release tablets in combination with olanzapine for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Invega Paliperidone ER (paliperidone)
• Zyprexa (olanzapine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED